Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × OTHER × Myasthenic Syndromes, Congenital × Clear all

Status

Completed 2 No longer available 1 Approved for marketing 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Conditions

Prostatic Neoplasms 5 Recurrence 2 Neoplasms 2 Lambert-Eaton Myasthenic Syndrome 2 Carcinoma, Hepatocellular 2 Wounds and Injuries 1 Renal Insufficiency 1 Prostatic Diseases 1 Pheochromocytoma 1 Paraganglioma 1 Osteosarcoma 1 Myasthenic Syndromes, Congenital 1 Lymphoma 1 Liver Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Congenital Abnormalities 1 Colonic Neoplasms 1

Interventions

Amifampridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00872950 2022-04-11

LEMS

Lahey Clinic

Approved for marketing

Lambert-Eaton Myasthenic Syndrome, Myasthenic Syndromes, Congenital

Data powered by HemOnc (CC BY 4.0) Colophon ⚡